MyoTrack measures how fast a child's short-sightedness is progressing, compares it to what you'd expect without treatment, and turns the answer into a report a parent actually understands — from the spectacle prescription you already take.
No spreadsheet, no flipping back through three years of cards to work out whether anything has changed.
Most myopia software assumes you can measure axial length; outside ophthalmology, very few South African practices can. MyoTrack is built the other way round: cycloplegic refraction is a first-class measurement with its own thresholds. Axial length is there if you have it — and if you buy a biometer later, every existing record keeps working.
Controlled, borderline or rapid — with the arithmetic shown underneath, so you can always see exactly how the answer was reached.
Record an optical modality, an atropine concentration, or both together with your instructions to the family. Outcomes attach to what the child was really on.
One page, plain language, your practice branding. The growth chart shades the gap between where the child is and where they'd have been untreated.
A welcome email when a child joins and a progress email after each review — on the same infrastructure as DryCheck.
Overdue and due-soon children are queued with the message drafted. Every send is logged against the child's record.
Mean progression by prescription, treatment mix, overdue reviews, programme value — numbers about your own patients no practice can currently produce.
Parents agree to treatment when they understand what's at stake. MyoTrack has a chairside explainer built in: the family drags a slider, the eye stretches, the picture blurs, and the named risks escalate as it goes. Then it draws their own child's road to age seventeen — treated versus untreated.
Every threshold and age-expected growth figure lives in one versioned configuration, signed off by a named clinical advisor and referenced to published literature. Each verdict is stamped with the version that produced it.
MyoTrack reports the slowing it has actually measured in that child. A change smaller than the repeatability of the measurement is reported as no change — never as a success.
MyoTrack does not diagnose and does not prescribe — every clinical decision is recorded against the practitioner who made it.
Guardian consent is captured, with a name and a date, before anything clinical can be stored.
Free while your practice is in the pilot programme. Billed monthly at launch, in Rand.
Already running DryCheck? MyoTrack is its sibling — same dashboards, same practice palettes, same email setup. Your team already knows how to use it.
No. MyoTrack is built around cycloplegic refraction, which is how the large majority of South African practices monitor myopia. Refraction has its own progression thresholds and its own age-expected comparison. If you do have a biometer, axial length is recorded alongside and takes precedence — and if you buy one later, every existing record keeps working.
Yes. A plan is an optical modality, an atropine concentration, or both together, with the instructions you gave the family. Adding atropine to a spectacle lens is recorded as one plan, and outcomes are attributed to what the child was actually on at the time.
The target is under two minutes on a tablet, and MyoTrack times itself so you can see whether the practice is hitting it. Sphere, cylinder and axis per eye, with the spherical equivalent calculated automatically.
A one-page report in plain language — the growth chart, whether the treatment is working, what you're doing, and what to do at home — plus a welcome email when their child joins and a progress email after each review.
Built by a South African optometrist who was tired of eyeballing old scripts to answer the question every parent asks. Pilot practices help shape the product and get early access.